CVR 57175516Public limited company (A/S)Engroshandel med medicinalvarer og sygeplejeartikler (464610)Secondary industries: Udlejning af erhvervsejendomme (682040)Vassingerødvej 9, 3540 LyngeFounded 20 Oct 1981
Compare withsimilar companiesanother companyits industry
MISSIONPHARMA PROPERTIES A/S
The newest trades with a company on a side are on the latest property trades.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Cite as: MISSIONPHARMA PROPERTIES A/S, https://dandex.ai/company/57175516/missionpharma-properties. Source: Dandex, from CVR, read 22 Nov 2026.
Dandex is Danish Company Data. Connect it once and ask about MISSIONPHARMA PROPERTIES A/S, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Dandex has an MCP server at https://dandex.ai/mcp and a REST API at https://dandex.ai/api/v1.
Set up DandexEmployees
1
CVR, 2012
Revenue
3M
DKK, annual report 2016
+2.5% on 2015
Result
+2M
DKK, annual report 2016
Equity
58.7M
DKK, annual report 2016
MISSIONPHARMA GROUP ApSCVR 29782792, 100% of capital and votes, until 29 May 2017
Poul Lindofuntil 29 May 2017
Kim Erik Ginnerupuntil 29 May 2017
No current owner is registered.
CVR 29782792100% of capital and votes15 Jul 2012 to 29 May 2017
CVR lists no current officers for this company.
2012, annual: 1 employee, 1 FTE
Arrow keys move through the periods, Home and End go to the first and the latest, Escape returns to the latest.
| Period | 1997 | 1998 | 1999 | 2000 | 2001 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | Q1 2010 | Q2 2010 | Q3 2010 | 2011 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employees | 37 | 25 | 76 | 32 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 1 | No count | No count | No count | 1 | 1 |
| FTE | 26 | 27 | 26 | 27 | 1 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 0 | 0 | 0 | 1 | 1 |
| Series | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Annual | Quarterly | Quarterly | Quarterly | Annual | Annual |
The legal entity's headcount in CVR, not the annual report's average, which may cover a group.
Source: CVR, latest 2012, published 24 Jun 2014.
The company's own figures, in DKK, from the annual reports filed in XBRL.
2016, DKK: Revenue 3M, Gross profit not reported, Operating profit 753.6K, Result for the year 2M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
2016, DKK: Total assets 70.2M, Equity 58.7M
Arrow keys move through the years, Home and End go to the first and the latest, Escape returns to the latest.
| DKK thousands | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Revenue | 3,708 | 2,819 | 2,837 | 2,889 | 2,962 |
| Gross profit | 2,683 | 2,313 | Not reported | Not reported | Not reported |
| Operating profit | +1,457 | +979 | +1,159 | +722 | +754 |
| Result for the year | +1,754 | +2,314 | +1,920 | +1,868 | +1,994 |
| Equity | 50,127 | 52,850 | 54,886 | 56,754 | 58,747 |
| Total assets | 67,785 | 68,960 | 69,069 | 69,319 | 70,167 |
Not every period is a full year: 2012 covers 8 months (1 May to 31 Dec 2012). Changes against it compare periods of different length.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingNot read from the announcement | None | None | None | 1,000,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2012 | 2013 | 2014 | 2015 | 2016 |
|---|---|---|---|---|---|
| Revenue growth (omsætningsvækst) | Not reportednote 1 | -24% | 0.6% | 1.9% | 2.5% |
| EBIT margin (overskudsgrad) | 39.3% | 34.7% | 40.9% | 25% | 25.5% |
| EBITDA | 2,375 | 2,273 | 2,453 | 2,025 | 2,067 |
| EBITDA margin (EBITDA-margin) | 64.1% | 80.6% | 86.5% | 70.1% | 69.8% |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | ||||
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | ||||
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | ||||
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | ||||
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | ||||
| Capex (investeringer i anlægsaktiver) | Not reportednote 2 | 0note 3 | Not reportednote 2 | 405note 3 | 0note 3 |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | ||||
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | ||||
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions.
How each credit metric is calculated:
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
Merger (fusion), as the ceasing company (ophørende selskab)
Source: CVR, read 22 Nov 2026.
28 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Erhvervsstyrelsen har modtaget oplysning om, at der er truffet beslutning om nedenstående fusion.
Virksomheden er d. 29.05.2017 opløst ved fusion med CVR-nummer: 26902398 MISSIONPHARMA A/S.
Erhvervsstyrelsen har modtaget fusionsplan for den påtænkte fusion mellem CVR-nummer: 26902398 MISSIONPHARMA A/S (fortsættende), der tillige driver virksomhed under navnene MISSIONPHARMA INTERNATIONAL PROJECT SERVICES A/S, MISSIONPHARMA INTERNATIONAL RELIEF SERVICES A/S, MISSIONPHARMA INTERNATIONAL A/S, INTERNATIONAL PROJECT SERVICES A/S og CVR-nummer: 57175516 MISSIONPHARMA PROPERTIES A/S (ophørende), der tillige driver virksomhed under navnene MISSIONPHARMA EJENDOMME A/S.
Der er endvidere modtaget erklæring fra vurderingsmændene om, at kreditorerne i CVR-nummer: 26902398 MISSIONPHARMA A/S og CVR-nummer: 57175516 MISSIONPHARMA PROPERTIES A/S må antages at være tilstrækkeligt sikrede efter fusionen.
CVR-nummer
57175516.
NAVN:
MISSIONPHARMA PROPERTIES A/S.
Adresse: Vassingerødvej 9, 3540 Lynge.
Kommune: Allerød.
Revision:
Fratrådte:
KPMG STATSAUTORISERET REVISIONSPARTNERSELSKAB, den 20.04.2015.
Tiltrådte:
CVR-NR. 33771231 PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB, Strandvejen 44, 2900 Hellerup, den 20.04.2015.
Direktion:
Udtrådt af direktionen:
Mikkel Mørkedal Wakefield, den 15.03.2013.
Indtrådt i direktionen:
Direktør Kim Erik Ginnerup (adm. dir), den 15.03.2013.
Direktion:
Udtrådt af direktionen:
Paule Georgette Ginnerup, den 30.11.2012.
Indtrådt i direktionen:
Mikkel Mørkedal Wakefield (adm. dir), den 30.11.2012, Direktør Poul Lindof (Økonomidirektør), den 30.11.2012.
Vedtægter ændret:
20.11.2012.
Revision:
Udtrådt af revisionen:
CVR-NR. 26052394 ERNST & YOUNG P/S, den 20.11.2012.
Indtrådt i revisionen:
CVR-NR. 30700228 KPMG STATSAUTORISERET REVISIONSPARTNERSELSKAB, Osvald Helmuths Vej 4, postboks 250, 2000 Frederiksberg, den 20.11.2012.
Regnskabsår ændret til:
01.01 - 31.12.
Omlægningsperiode:
01.05.2012 - 31.12.2012.
Vedtægter ændret:
01.11.2012.
Bestyrelse:
Udtrådt af bestyrelsen:
Paule Georgette Ginnerup, den 01.11.2012, Benedicte Ginnerup, den 01.11.2012, Søren Hedemand Jacobsen, den 01.11.2012.
Indtrådt i bestyrelsen:
Jean-Marc Pierre Rene Leccia (formand), den 01.11.2012, Denis Georges Fernand Maurice (næstformand), den 01.11.2012, Eric Pierre Jean Muris, den 01.11.2012.
Selskabets tegnes af to bestyrelsesmedlemmer i forening, af tre direktører i forening, af næstformanden for bestyrelsen i forening med en direktør eller af den sam-lede bestyrelse.
Vedtægter ændret:
27.09.2010.
Bestyrelse:
Udtrådt af bestyrelsen:
Erik Schou Stavnstrup, den 31.10.2006.
Indtrådt i bestyrelsen:
Kontorassistent Benedicte Ginnerup, den 31.10.2006.
Bestyrelse:
Udtrådt af bestyrelsen:
Leif Ole Lund-Andersen, Jesper Funding Andersen, den 29.01.2003, Alan Per Binau, den 29.01.2003.
Bestyrelse:
Tiltrådt som formand:
Leif Ole Lund-Andersen, den 11.12.2002, Fratrådt som formand, men forbliver i bestyrelsen: Paule Georgette Ginnerup, den 11.12.2002.
Direktion:
Udtrådt af direktionen:
Kim Erik Ginnerup, den 11.12.2002.
Indtrådt i direktionen:
Direktør Paule Georgette Ginnerup (adm. dir), den 11.12.2002.
Slettet binavn: MISSIONPHARMA EJENDOMMEN A/S (MISSIONPHARMA PROPERTIES A/S).
Nyt binavn: MISSIONPHARMA EJENDOMME A/S (MISSIONPHARMA PROPERTIES A/S).
Vedtægter ændret:
02.12.2002.
Nyt navn:
MISSIONPHARMA PROPERTIES A/S.
Nyt binavn: MISSIONPHARMA EJENDOMMEN A/S (MISSIONPHARMA PROPERTIES A/S).
Bestyrelse:
Tiltrådt som formand:
Paule Georgette Ginnerup, den 07.07.1999.
Direktion:
Udtrådt af direktionen:
Paule Georgette Ginnerup, den 07.07.1999, den 07.07.1999.
Indtrådt i direktionen:
Direktør Kim Erik Ginnerup (adm. dir), den 07.07.1999.
Bestyrelse:
Udtrådt af bestyrelsen:
Oluf Ginnerup, den 25.06.1998, Benedicte Ginnerup, den 25.06.1998.
Indtrådt i bestyrelsen:
Jesper Funding Andersen, den 25.06.1998.
Revision:
Udtrådt af revisionen:
Revisor Martin Lind.
Indtrådt i revisionen:
REVISIONSFIRMAET NIELS HARDER A/S, Rådmandsgade 45, 2200 København N, den 10.01.1996.
Ny adresse:
Vassingerødvej 9, 3540 Lynge.
Bestyrelse:
Udtrådt af bestyrelsen:
Indtrådt i bestyrelsen:
Kim Erik Ginnerup, Fru Paule Georgette Ginnerup
Direktion:
Udtrådt af direktionen:
Bestyrelse:
Indtrådt i bestyrelsen:
Jannik Kenneth Rosenkrans Jensen, Erik Schou Stavnstrup
Direktion:
Indtrådt i direktionen:
Stiftelsesdato:
20.10.1981
Seneste vedtægtsdato:
28.11.1985
Kapital:
kr. 1.000.000,00
Indbetalingsmåde:
kontant/i værdier kr. 1.000.000,00 til kurs 100,0
Bestyrelse:
Overlæge Oluf Ginnerup, Direktør Poul Ginnerup, Advokat Leif Ole Lund-Andersen
Direktion:
Direktør Poul Ginnerup
Selskabet tegnes af en direktør alene eller
af den samlede bestyrelse
Revision:
Revisionsfirmaet Erik Nielsen - J.A. Aundrup - Niels Harder, 2200 København N
Første regnskabsår:
00.00 - 00.00
Regnskabsår:
01.05 - 30.04
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 22 Nov 2026.
What Pro holds for MISSIONPHARMA PROPERTIES A/S:
Have Pro? Sign in.
P-number 1007566847Vassingerødvej 9, 3540 Lynge
P-number 1002058437Vassingerødvej 9, 3540 Lynge